Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 105

1.

Renal dysfunction after liver transplantation: effect of donor type.

Kollmann D, Neong SF, Rosales R, Hansen BE, Sapisochin G, McCluskey S, Bhat M, Cattral MS, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M, Wong FSH, Selzner N.

Liver Transpl. 2020 Mar 19. doi: 10.1002/lt.25755. [Epub ahead of print]

PMID:
32189415
2.

Pediatric living donor liver transplantation with large-for-size left lateral segment grafts.

Goldaracena N, Echeverri J, Kehar M, DeAngelis M, Jones N, Ling S, Kamath BM, Avitzur Y, Ng VL, Cattral MS, Grant DR, Ghanekar A.

Am J Transplant. 2020 Feb;20(2):504-512. doi: 10.1111/ajt.15609. Epub 2019 Nov 1.

PMID:
31550068
3.

Diagnosis, Outcome, and Management of Chylous Ascites Following Pediatric Liver Transplantation.

Miserachs M, Lurz E, Levman A, Ghanekar A, Cattral M, Ng V, Grant D, Avitzur Y.

Liver Transpl. 2019 Sep;25(9):1387-1396. doi: 10.1002/lt.25604. Epub 2019 Aug 6.

PMID:
31301267
4.

Donor outcomes in anonymous live liver donation.

Goldaracena N, Jung J, Aravinthan AD, Abbey SE, Krause S, Pritlove C, Lynch J, Wright L, Selzner N, Stunguris J, Greig P, Ghanekar A, McGilvray I, Sapisochin G, Ng VL, Levy G, Cattral M, Grant D.

J Hepatol. 2019 Nov;71(5):951-959. doi: 10.1016/j.jhep.2019.06.027. Epub 2019 Jul 4.

PMID:
31279899
5.

The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.

Aravinthan AD, Fateen W, Doyle AC, Venkatachalapathy SV, Issachar A, Galvin Z, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Grant DR, Selzner N, Lilly LB, Renner EL, Bhat M.

Transplantation. 2019 Dec;103(12):2523-2530. doi: 10.1097/TP.0000000000002757.

PMID:
30985734
6.

Passenger Lymphocyte Syndrome After Pediatric Liver Transplantation.

Woolfson JP, Vandriel SM, Stephens D, Dharmaraj BG, De Angelis M, Cattral MS, Ghanekar A, Grant DR, Avitzur Y, Ng VL.

J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):95-101. doi: 10.1097/MPG.0000000000002337.

PMID:
30889120
7.

Superior Outcomes and Reduced Wait Times in Pediatric Recipients of Living Donor Liver Transplantation.

Kehar M, Parekh RS, Stunguris J, De Angelis M, Van Roestel K, Ghanekar A, Cattral M, Fecteau A, Ling S, Kamath BM, Jones N, Avitzur Y, Grant D, Ng VL.

Transplant Direct. 2019 Feb 27;5(3):e430. doi: 10.1097/TXD.0000000000000865. eCollection 2019 Mar.

8.

Caval Replacement With Cadaveric External Iliac Vein in Pediatric Liver Transplant: Internal Iliac Vein as Optimal Site for Outflow Anastomosis.

Goldaracena N, Sayed BA, Cattral MS.

Liver Transpl. 2019 Jun;25(6):964-966. doi: 10.1002/lt.25440. Epub 2019 Apr 10. No abstract available.

PMID:
30854773
9.

Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.

Goldaracena N, Gorgen A, Doyle A, Hansen BE, Tomiyama K, Zhang W, Ghanekar A, Lilly L, Cattral M, Galvin Z, Selzner M, Bhat M, Selzner N, McGilvray I, Greig PD, Grant DR, Sapisochin G.

J Hepatol. 2019 Apr;70(4):666-673. doi: 10.1016/j.jhep.2018.12.029. Epub 2019 Jan 8.

PMID:
30630009
10.

Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.

J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.

PMID:
30615906
11.

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.

Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M.

Liver Transpl. 2019 Jan;25(1):56-67. doi: 10.1002/lt.25338.

12.

Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.

Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Nov;24(11):1512-1522. doi: 10.1002/lt.25197.

13.

Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.

Linares I, Goldaracena N, Rosales R, Maza L, Kaths M, Kollmann D, Echeverri J, Selzner N, McCluskey SA, Sapisochin G, Lilly LB, Greig P, Bhat M, Ghanekar A, Cattral M, McGilvray I, Grant D, Selzner M.

Liver Transpl. 2018 Sep;24(9):1209-1220. doi: 10.1002/lt.25212.

14.

Risk factors for surgical site infection after kidney and pancreas transplantation.

Natori Y, Albahrani S, Alabdulla M, Vu J, Chow E, Husain S, Kumar D, Humar A, Schiff J, Cattral M, Rotstein C.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1042-1048. doi: 10.1017/ice.2018.148. Epub 2018 Jul 13.

PMID:
30001758
15.

Tumor Dendritic Cells (DCs) Derived from Precursors of Conventional DCs Are Dispensable for Intratumor CTL Responses.

Diao J, Gu H, Tang M, Zhao J, Cattral MS.

J Immunol. 2018 Aug 15;201(4):1306-1314. doi: 10.4049/jimmunol.1701514. Epub 2018 Jul 11.

16.

Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.

Goldaracena N, Barbas AS, Galante A, Sapisochin G, Al-Adra D, Selzner N, Galvin Z, Cattral MS, Greig PD, Lilly L, Bhat M, McGilvray ID, Ghanekar A, Levy G, Grant DR, Selzner M.

Clin Transplant. 2018 Aug;32(8):e13304. doi: 10.1111/ctr.13304. Epub 2018 Jul 16.

PMID:
29947154
17.

Liver Transplantation Without Venovenous Bypass: Does Surgical Approach Matter?

Barbas AS, Levy J, Mulvihill MS, Goldaracena N, Dib MJ, Al-Adra DP, Cattral MS, Ghanekar A, Greig PD, Grant DR, Sapisochin G, Selzner M, McCluskey SA, McGilvray ID.

Transplant Direct. 2018 Apr 24;4(5):e348. doi: 10.1097/TXD.0000000000000776. eCollection 2018 May.

18.

Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.

Kollmann D, Sapisochin G, Goldaracena N, Hansen BE, Rajakumar R, Selzner N, Bhat M, McCluskey S, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Jun;24(6):779-789. doi: 10.1002/lt.25068. Epub 2018 May 14.

19.

Surgical Complications after Right Hepatectomy for Live Liver Donation: Largest Single-Center Western World Experience.

Gorgen A, Goldaracena N, Zhang W, Rosales R, Ghanekar A, Lilly L, Cattral M, Greig P, McCluskey S, McGilvray I, Selzner N, Bhat M, Selzner M, Levy G, Grant D, Sapisochin G.

Semin Liver Dis. 2018 May;38(2):134-144. doi: 10.1055/s-0038-1636932. Epub 2018 Mar 22.

PMID:
29566408
20.

Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent.

Muaddi H, Al-Adra DP, Beecroft R, Ghanekar A, Moulton CA, Doyle A, Selzner M, Wei A, McGilvray ID, Gallinger S, Grant DR, Cattral MS, Greig PD, Kachura J, Cleary SP, Sapisochin G.

Ann Surg Oncol. 2018 Apr;25(4):991-999. doi: 10.1245/s10434-017-6329-x. Epub 2018 Jan 11.

PMID:
29327179

Supplemental Content

Loading ...
Support Center